- Home
- NWE vs TERN Comparison
NWE vs TERN Comparison
Compare NWE & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWE | TERN |
|---|---|---|
| Founded | 1923 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NWE | TERN |
|---|---|---|
| Price | $66.67 | $44.05 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $60.00 | $48.60 |
| AVG Volume (30 Days) | 594.5K | ★ 5.2M |
| Earning Date | 10-29-2025 | 11-10-2025 |
| Dividend Yield | ★ 3.89% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.53 | N/A |
| Revenue | ★ $1,569,761,000.00 | N/A |
| Revenue This Year | $6.08 | N/A |
| Revenue Next Year | $4.48 | N/A |
| P/E Ratio | $19.22 | ★ N/A |
| Revenue Growth | ★ 4.90 | N/A |
| 52 Week Low | $50.43 | $1.87 |
| 52 Week High | $69.23 | $48.26 |
Technical Indicators
Market Signals| Indicator | NWE | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 55.35 | 78.03 |
| Support Level | $65.05 | $25.67 |
| Resistance Level | $68.58 | $48.26 |
| Average True Range (ATR) | 1.25 | 3.39 |
| MACD | -0.20 | 1.24 |
| Stochastic Oscillator | 38.71 | 81.36 |
Price Performance
Historical ComparisonAbout NWE NorthWestern Energy Group Inc.
NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric utility operations, which include the generation, purchase, transmission, and distribution of electricity, and Natural Gas utility operations, which include the production, purchase, transmission, storage, and distribution of natural gas. The company uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric utility operations segment.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.